M
0.220
0.01 (4.76%)
Previous Close | 0.210 |
Open | 0.215 |
Volume | 115,431 |
Avg. Volume (3M) | 831,955 |
Market Cap | 121,416,024 |
Price / Sales | 1.12 |
Price / Book | 2.40 |
52 Weeks Range | |
Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
Profit Margin | 0.65% |
Operating Margin (TTM) | -11.56% |
Quarterly Revenue Growth (YOY) | 37.40% |
Quarterly Earnings Growth (YOY) | 49.50% |
Total Debt/Equity (MRQ) | 24.44% |
Current Ratio (MRQ) | 0.710 |
Operating Cash Flow (TTM) | 5.19 M |
Levered Free Cash Flow (TTM) | 3.12 M |
Return on Assets (TTM) | 1.79% |
Return on Equity (TTM) | 1.58% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (AU) | Mixed | Mixed |
Health Information Services (Global) | Mixed | Bearish | |
Stock | MEDADVISOR FPO [MDR] | - | - |
AIStockmoo Score
0.1
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -2.5 |
Average | 0.13 |
MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Growth |
% Held by Insiders | 41.90% |
% Held by Institutions | 15.36% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |